1889 Prospective, non-randomised, open-label study of UDPgluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics (PK) in post-menopausal hormone receptor (HR)-positive Asian metastatic breast cancer (MBC) patients progressing after prior endocrine therapy. (September 2015) - Wong, A.; Wang, L.Z.; Wong, F.C.; Ow, S.; Nesaretnam, K.; Pang, A.; Tan, C.S.; Lim, Y.W.; Ho, G.F.; Lee, Y.; Yap, H.L.; Phang, S.; et al.